Acceleron Pharma

+$0.78 (+0.64%) As of 7:24 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XLRN and other ETFs, options, and stocks.

About XLRN

Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension.

CEO
Habib J. Dable
Employees
312
Headquarters
Cambridge, Massachusetts
Founded
2003

XLRN Key Statistics

Market Cap
7.71B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
303.98K
High Today
$123.81
Low Today
$120.76
Open Price
$122.70
Volume
80.91K
52 Week High
$146.15
52 Week Low
$85.58

XLRN Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure